Successful Therapy with intravenous gamma globulin in two children with postinfectious bronchiolitis obliterans
Journal Title: Journal of Pulmonology and Respiratory Research - Year 2017, Vol 1, Issue 1
Abstract
Bronchiolitis obliterans (BO) is an infrequent clinical syndrome characterized by the chronic obstruction of small airways due to fibrosis [1]. Intravenous immunoglobulin (IVIG) could be used for treatment while underlying immune mechanisms in the pathogenesis of BO exist [2]. Here, we present two children with BO due to adenovirus infection whose complaints resolved after IVIG replacement.
Authors and Affiliations
Sevgi Pekcan, Bahar Gökturk, Ismail Reisli
Keywords
Related Articles
- EP ID EP560443
- DOI 10.29328/journal.jprr.1001003
- Views 41
- Downloads 0
COPD and low plasma vitamin D levels: Correlation or causality?
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death and its prevalence and incidence is also related to smoking behavior [1]. COPD is still a chronic inflammatory and progressive disease caus...
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.i.d. in asthma patients: a 12-week pilot study
Two of the most recent LABA/ICS combinations for treatment of persistent asthma are Fluticasone furoate/Vilanterol 92/22 µg (Ellipta) and Beclomethasone dipropionate/Formoterol 100/6 µg (Nexthaler).
A decade of targeted therapy for non-small cell lung cancer
Chemotherapy is one of the main treatment options for cancer. However, chemotherapeutic agents usually suffer from poor pharmaceutical properties that restrict their use. Targeted therapy drugs have been developed to spe...
Avoiding confusion in high flow oxygen therapy concepts
Oxygen therapy is the main supportive treatment in hypoxemic respiratory failure and has traditionally been delivered using low and high flow devices. However, the maximal flow rates that these devices can deliver are li...
Successful treatment of late-onset pulmonary hypertension after atrial septal defect operation with macitentan: Our center experience
Background: Macitentan significantly improves pulmonary hemodynamics and survival in patients with primary pulmonary hypertension (PPH). Its beneficial effect, however, may be blunted due to the adverse impacts such as a...